PLAT and COVID-19: This was in contrast to the ratio in control plasma samples (where PAI-1 levels averaged more than tenfold greater than tPA) or in COVID-19 patients with tPA less than 20 ng/mL (where PAI-1 levels were > twofold greater than tPA).